Results 231 to 240 of about 91,337 (260)

Diagnostic sequencing identifies high-risk markers and mechanisms of resistance to guide immunotherapy selection. [PDF]

Blood Adv
Sudha P, Pham P, Niu W, Liu E, Wang L, Truong G, Ligocki C, Al-Azzawi R, Surapenini M, Bray SM, Vetrini F, Czader M, Tayeh MK, Lee K, Abonour R, Suvannasankha A, Walker BA.   +16 more
europepmc   +1 more source

Propagation of monocyte exhaustion memory and underlying mechanisms. [PDF]

Cell Commun Signal
Wang J, Caldwell BA, Wu Y, Razani B, Li L.   +4 more
europepmc   +1 more source

Engineering of induced pluripotent stem cells for the efficient development of non-alloreactive, hypoimmunogenic CD8αβ CAR-T cells. [PDF]

Front Immunol
Nianias A, Katsarou A, Prins HJ, Shahrabi A, van Velzen C, Henneman L, Ruiter R, Mutis T, Groen R, Themeli M.   +9 more
europepmc   +1 more source

Correlation Between CD38⁺ Cell Levels and Pulmonary Tuberculosis Complicated with Diabetes Mellitus: A Retrospective Analysis Based on Lymphocyte Subsets and Clinical Features. [PDF]

Diabetes Metab Syndr Obes
Wang Y, Mao W, Xu L, Xu W.
europepmc   +1 more source

Real-world outcomes in patients with relapsed and refractory multiple myeloma with prior proteasome inhibitor and lenalidomide exposure: A single-center study in Sweden. [PDF]

Clin Hematol Int
Luong V, Kashif M, Uttervall K, Bohlin A, Öster Fernström A, Qu Y, Lee S, Mendes J, Van Hoorenbeeck S, Hellqvist Franck E, He J, Alici E, Lund J.   +12 more
europepmc   +1 more source

Immune cells and rheumatic heart disease: A 2-sample and Bayesian weighted Mendelian randomization study. [PDF]

Medicine (Baltimore)
Xue S, Jiang H, Liu C, Zhou Y.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

CD38 KO/CD38-CAR Human Primary Natural Killer Cells Enhance Cytotoxicity Against CD38-Expressing Primary Lymphoma, Leukemia, and Myeloma

Blood, 2023
Natural killer (NK) cells have strong cancer immunotherapeutic potential that can be further augmented by engineering with a chimeric antigen receptor (CAR). CD38, a transmembrane glycoprotein involved in signal transduction and cellular adhesion, is highly expressed on the surface of the hematologic malignancies multiple myeloma (MM ...
Ella C Troy, Yasemin Sezgin, Marcelo De Souza Pereira, Joseph Caporale, Gregory K Behbehani, Justin Lyberger, Dean Anthony Lee, Meisam Naeimi Kararoudi   +7 more
openaire   +1 more source

Murine CD38: an immunoregulatory ectoenzyme

Immunology Today, 1995
CD38 is an ectoenzyme that utilizes NAD+ and is expressed by many cells of hematopoietic origin. Antibodies to CD38 potentiate many biological activities on lymphocytes, including induction of murine B-cell proliferation. In this article, Frances Lund and colleagues summarize information concerning the expression, enzymatic activity and signal ...
Frances Lund, Nanette Solvason, J.Christopher Grimaldi, R. Michael, E. Parkhouse, Maureen Howard   +5 more
openaire   +2 more sources